The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
|Articles|October 1, 2005
- Volume 0 0
Drug Chains Urge National OTC Drug Rules
Author(s)Ken Rankin
Advertisement
A flurry of new and conflicting stateand local laws regulating the sale ofOTC cold products containing pseudoephedrineis creating complianceproblems for drug chains operating inmultiple jurisdictions.
Chain drugstore leaders urged Congressto adopt a national standard forthe sale of OTC cold drugs. They warnedthat a "patchwork" system of differingstate and local restrictions on the sale ofthese drugs will actually play into thehands of criminals seeking source materialfor illegal methamphetamine.
Mr. Rankin is a freelance medical writer.
Articles in this issue
about 21 years ago
A Pharmacist's Guide to OTC Therapy: Ocular Care Productsabout 21 years ago
Dangerous Liaisons: Schizophrenia and Diabetesabout 21 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Nutritional Supplementsabout 21 years ago
Tarceva Extends Lung Cancer Survivalabout 21 years ago
Inhaled Morphine Aids Cancer-related Dyspneaabout 21 years ago
Diuretic Best BP Therapy for African Americansabout 21 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Foot Care Productsabout 21 years ago
New Drug Blocks Out AIDS Virusabout 21 years ago
Viagra Ingredient Has Another Useabout 21 years ago
GUEST COMMENTARY: FIGHTING THE NEW PHARMACOPHOBIAAdvertisement
Related to this article
Persistent symptoms can complicate life after a multiple myeloma treatment response, making routine symptom assessment and targeted supportive care essential.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
Convenience should not replace connection.
Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
A pharmacy technician reflects on 3 patient encounters that reshaped his
understanding of what a real patient requires.
In a Korean cohort of 1861 patients with nondialysis CKD, intake below 0.6 g/kg per day was linked to more kidney failure and higher all-cause mortality.
Doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (Voceryq) targets HPV-6 and HPV-11 to reduce the surgical burden for adults with recurrent respiratory papillomatosis, a rare airway disease.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Community Pharmacists Guide Patients New to Glucose Monitoring
2
FDA Approves Tildrakizumab for Adults With Psoriatic Arthritis
3
Early Nirmatrelvir/Ritonavir Linked to Lower Long COVID Risk in High-Risk Outpatients
4
Very Low Protein Intake Tied to Higher Kidney Failure Risk in CKD
5